About the protocol bench

Why the set stays at seven

A directory that tries to cover every tablet on a formulary cannot argue any of them. This bench keeps seven locks, one comparison and seven briefings so each page can still be checked against the live label. No bottle leaves this address. No chain is ranked. No manufacturer buys a sentence.

What sits on the tray

Three phosphodiesterase-5 inhibitors for erectile dysfunction: tadalafil (Cialis) locked at 10-20 mg as needed, sildenafil (Viagra) locked at 50 mg, and vardenafil (Levitra) locked at 10-20 mg. One fluoroquinolone, ciprofloxacin (Cipro) at 750 mg. One nerve-pain and seizure drug, gabapentin (Neurontin) at 600 mg. Two antiparasitics: mebendazole as Emverm 100 mg in a two-dose pinworm course, and ivermectin (Stromectol) 3 mg counted at 200 mcg/kg. A lighter briefing sits beside each lock for the question people actually type.

How a lock is issued

The method is Plot, Trace, Bench, Issue. The title line holds one labelled strength. The body may name the rest of the ladder. Cash windows use sourced dollars only. Middle chapters move per sheet so two locks never share the same spine.

Who signs it

Every draft goes to Dr. Lena Hofer. Her name, field and profile stay on the issued sheet. A named internist in Wien is worth more than an anonymous medically-reviewed stamp.

What we open to write it

Current FDA prescribing information first, then EMA assessments, WHO monographs where they apply, MedlinePlus, and named trials. If this site and the live label disagree, the label wins. That includes the nitrate ban on the PDE5 tablets and the fluoroquinolone boxed warning.

How to reach the bench

Corrections and label updates go to [email protected] or the contact page. A sheet is re-opened when the prescribing information actually moves.